NIH Information Quality

Draft RoC Monograph for ortho-Toluidine

Document, Report, or Other Product Information
Title: Draft RoC Monograph for ortho-Toluidine
Subject: The Draft RoC Monograph for ortho-Toluidine consists of two parts: (1) a cancer evaluation component that reviews the relevant carcinogenicity information, assesses its quality, applies the RoC listing criteria, and recommends a RoC listing status for ort
Purpose (e.g., abstract): The Draft RoC Monograph for ortho-Toluidine is being distributed to receive public and peer-review comments by a scientific panel at a public meeting
Link to Information Product:
IC Division, Office, or Program: ORoC
NIH Contact: Mary Wolfe
Review Description: Peer review of the draft monograph for ortho-Toluidine.
Date of Review: December 12-13, 2013
Reviewer Names and Expertise
Number of Reviewers: 7-9
Reviewer Nominations Requested? No
Upcoming Panels, Events: View Upcoming Panels, Events, Notices, Meeting Updates
Technical/Draft Reports, Public Comments and Presentations:
Past Roster, Notices, Meeting UPdates: View Past Roster, Notices, Meeting Updates
Reviewer Expertise: pathology, toxicology, carcinogenesis, genetic toxicology, epidemiology
How Selected: National Toxicology Program
Opportunity for Public Comment? Yes